Cannigistics Enters into MOU for Clinical Trials Software Platform
Cannigistics Enters into Memorandum of Understanding for Clinical Trials Software Platform March 16, 2015 – Vancouver, British Columbia – Calyx Bio-Ventures Inc. (TSXV:CYX) (“Calyx” or “the Company”) is pleased to announce that its wholly-owned subsidiary, Cannigistics Agri-Solutions Corp. (“Cannigistics”), has entered into a memorandum of understanding (“MOU”) with a third party with respect to the […]
